ML15125A048
| ML15125A048 | |
| Person / Time | |
|---|---|
| Site: | Northwest Medical Isotopes |
| Issue date: | 06/01/2015 |
| From: | Michael Balazik Research and Test Reactors Branch B |
| To: | Haass C Northwest Medical Isotopes |
| Balazik M, NRR/DPR, 301-415-2856 | |
| Shared Package | |
| ML15125A174 | List: |
| References | |
| TAC MF6135 | |
| Download: ML15125A048 (4) | |
Text
June 1, 2015 Carolyn C. Haass Vice President Northwest Medical Isotopes, LLC 8815 Northwest 9th Street, Suite 256 Corvallis, OR 97330
SUBJECT:
NORTHWEST MEDICAL ISOTOPES, LLC - ACCEPTANCE FOR DOCKETING OF PART ONE OF THE APPLICATION FOR CONSTRUCTION PERMIT (TAC NO. MF6135)
Dear Ms. Haass:
On November 7, 2014, Northwest Medical Isotopes, LLC (NWMI) filed with the U.S. Nuclear Regulatory Commission (NRC) pursuant to Section 103 of the Atomic Energy Act, and Part 50 of Title 10 of the Code of Federal Regulations (10 CFR), a portion of an application for a construction permit for a medical radioisotope production facility in Columbia, Missouri. By letter dated February 5, 2015 (Agencywide Documents Access and Management System (ADAMS)
Accession No. ML15086A262, Package No. ML15086A261), NWMI withdrew and resubmitted this portion of its construction permit application to include a discussion of connected actions in its environmental report in response to a January 23, 2015, letter from the NRC (ADAMS Accession No. ML14349A501).
The NRC staff acknowledged receipt of part one of NWMIs two-part application for a construction permit under 10 CFR Part 50 in the Federal Register (80 FR 22227) on April 21, 2015. In response to a letter from NWMI dated August 9, 2013 (ADAMS Accession No. ML13227A295), an exemption from certain requirements of 10 CFR 2.101(a)(5) was granted by the NRC on October 7, 2013 (ADAMS Accession No. ML13238A333).
The exemption allowed NWMI to submit its construction permit application in two parts.
Specifically, the exemption allowed NWMI to submit a portion of its application for a construction permit up to six months prior to submitting the remainder of the application regardless of whether or not an environmental impact statement or a supplement to an environmental impact statement is prepared during the review of its application. On February 5, 2015, in accordance with 10 CFR 2.101(a)(5), NWMI submitted the following in part one of the construction permit application:
the description and safety assessment of the site required by 10 CFR 50.34(a)(1),
the environmental report required by 10 CFR 50.30(f),
the filing fee information required by 10 CFR 50.30(e) and 10 CFR 170.21, the general information required by 10 CFR 50.33, and the agreement limiting access to classified information required by 10 CFR 50.37.
As stated in NWMIs letter dated February 5, 2015, part two of NWMIs application for a construction permit will contain the remainder of the preliminary safety analysis report required by 10 CFR 50.34(a) and will be submitted in accordance with the requirements of 10 CFR 2.101(a)(5).
The NRC staff has reviewed part one of NWMIs application for a construction permit and determined that the submitted portion of the application is complete and acceptable for docketing. The docket number assigned to this project is 50-609. Please reflect this docket number on all future correspondence. A separate completeness and acceptability review will be performed upon receipt of part two of NWMIs application for a construction permit.
Enclosed is the notice that will be forwarded to the Federal Register, informing the public of the docketing of part one of NWMIs application for a construction permit.
The NRC staff intends to publish a review schedule for NWMIs construction permit application following the completion of the acceptance review for part two of the application. I will notify you when the NRC staff reaches a decision on how it will document its environmental review. The review schedule will reflect this decision.
If you have any questions, please contact me at Michael.Balazik@nrc.gov or 301-415-2856.
Sincerely,
/RA/
Michael Balazik, Project Manager Research and Test Reactors Licensing Branch Division of Policy and Rulemaking Office of Nuclear Reactor Regulation Docket No. 50-609
Enclosure:
Federal Register Notice cc: See next page
Northwest Medical Isotopes Docket Number: 50-609 cc:
Darrell Liles, CHP, PE Senior Health Physicist ARCADIS-SENES 8310 South Valley Highway Suite 135 Englewood, Colorado, 80112 Nicholas F. Fowler Chief Executive Officer Northwest Medical Isotopes, LLC 8815 Northwest 9th Street, Suite 256 Corvallis, OR 97330
Pkg: ML15125A174 Letter: ML15125A048 FRN: ML15125A016 Memo to ADM: ML15125A016